Phase 2 study to evaluate the clinical efficacy and safety of MEDI4736 in patients with glioblastoma (GBM) Meeting Abstract
| Authors: | Reardon, D. A.; Dietrich, J.; Kaley, T.; Gan, H.; Dunn, G. P.; Cloughesy, T.; Lim, M.; Clarke, J.; Park, A.; Pang, L.; Lai, D. W.; Karakunnel, J.; Robbins, P.; Narwal, R.; Venhaus, R. |
| Abstract Title: | Phase 2 study to evaluate the clinical efficacy and safety of MEDI4736 in patients with glioblastoma (GBM) |
| Meeting Title: | CRI-CIMT-EATI-AACR Inaugural International Cancer Immunotherapy Conference: Translating Science into Survival |
| Journal Title: | Cancer Immunology Research |
| Volume: | 4 |
| Issue: | Suppl. |
| Meeting Dates: | 2015 Sep 16-19 |
| Meeting Location: | New York, NY |
| ISSN: | 2326-6066 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2016-01-01 |
| Language: | English |
| ACCESSION: | WOS:000375484400041 |
| DOI: | 10.1158/2326-6074.cricimteatiaacr15-a046 |
| PROVIDER: | wos |
| PUBMED: | 27119139 |
| Notes: | Meeting Abstract: A046 -- Source: Wos |
